We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-0.35%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$23.6B
AUM Growth
-$1.36B
(-5.5%)
Cap. Flow
-$773M
Cap. Flow
% of AUM
-3.28%
Top 10 Holdings %
Top 10 Hldgs %
34.03%
Holding
1,274
New
126
Increased
411
Reduced
478
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$165M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$145M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$140M |
| 4 |
Salesforce
CRM
|
+$110M |
| 5 |
Eli Lilly
LLY
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$343M |
| 2 |
Intuitive Surgical
ISRG
|
+$173M |
| 3 |
Accenture
ACN
|
+$130M |
| 4 |
Hershey
HSY
|
+$127M |
| 5 |
Deere & Co
DE
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.05% |
| 2 | Financials | 13.6% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Healthcare | 10.63% |
| 5 | Industrials | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Century Communities
CCS
$2B
| $259K | ﹤0.01% |
+3,884
| New | +$283K |
|
1002
Anika Therapeutics
ANIK
$295M
| $259K | ﹤0.01% |
13,920
+4,410
| +46% | +$91.5K |
|
1003
Pure Cycle
PCYO
$273M
| $259K | ﹤0.01% |
26,940
+4,610
| +21% | +$52K |
|
1004
Southside Bancshares
SBSI
$979M
| $258K | ﹤0.01% |
+8,996
| New | +$268K |
|
1005
UGI
UGI
$7.53B
| $257K | ﹤0.01% |
11,164
-259,122
| -96% | -$6.43M |
|
1006
Stoneridge
SRI
$197M
| $256K | ﹤0.01% |
+12,732
| New | +$258K |
|
|
EVBG
1007
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $255K | ﹤0.01% |
11,358
-190
| -2% | -$4.9K |
|
1008
PNC Financial Services
PNC
$102B
| $253K | ﹤0.01% |
2,057
| – | – |
|
|
GBIO
1009
DELISTED
Generation Bio
GBIO
| $252K | ﹤0.01% |
6,637
| – | – |
|
|
MRSN
1010
DELISTED
Mersana Therapeutics
MRSN
| $251K | ﹤0.01% |
+7,899
| New | +$375K |
|
1011
National Presto Industries
NPK
$998M
| $249K | ﹤0.01% |
3,440
| – | – |
|
1012
Harmony Biosciences
HRMY
$2.32B
| $249K | ﹤0.01% |
7,593
-14,093
| -65% | -$489K |
|
1013
Trustmark
TRMK
$2.79B
| $248K | ﹤0.01% |
+11,430
| New | +$266K |
|
1014
iRhythm Holdings
IRTC
$4.13B
| $248K | ﹤0.01% |
2,629
+62
| +2% | +$6.3K |
|
1015
Arthur J. Gallagher & Co
AJG
$65.5B
| $248K | ﹤0.01% |
1,087
+25
| +2% | +$5.6K |
|
1016
NETSCOUT
NTCT
$2.87B
| $247K | ﹤0.01% |
8,805
-180
| -2% | -$5.15K |
|
|
MZTI
1017
The Marzetti Company
MZTI
$3.18B
| $246K | ﹤0.01% |
1,493
-2,241
| -60% | -$403K |
|
1018
First Financial Bancorp
FFBC
$3.58B
| $246K | ﹤0.01% |
+12,561
| New | +$269K |
|
|
SWAV
1019
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $246K | ﹤0.01% |
1,235
-24,044
| -95% | -$5.69M |
|
1020
Northrim BanCorp
NRIM
$599M
| $244K | ﹤0.01% |
+24,640
| New | +$265K |
|
1021
Terreno Realty
TRNO
$7.48B
| $244K | ﹤0.01% |
4,288
| – | – |
|
1022
Asana
ASAN
$2.07B
| $244K | ﹤0.01% |
13,299
+303
| +2% | +$6.33K |
|
1023
Ovintiv
OVV
$17.5B
| $242K | ﹤0.01% |
5,087
-2,003
| -28% | -$90.7K |
|
|
UHT
1024
Universal Health Realty Income Trust
UHT
$573M
| $240K | ﹤0.01% |
5,927
| – | – |
|
|
TBRG
1025
DELISTED
TruBridge
TBRG
| $239K | ﹤0.01% |
15,016
+5,060
| +51% | +$103K |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Los Angeles Capital Management held 1,274 positions worth $23.6B, down 5.5% from $24.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Los Angeles Capital Management withdrew a net $773M in Q3 2023, closing 172 positions and reducing 478 holdings. Its most notable exit was Paycom, an estimated $93.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Los Angeles Capital Management opened a new position in HF Sinclair worth $41.7M.
- Los Angeles Capital Management's largest Q3 2023 buy was HF Sinclair: 732,971 shares worth $41.7M.
- Los Angeles Capital Management added most to Berkshire Hathaway Class B in Q3 2023, an estimated $165M increase.
- Los Angeles Capital Management's biggest Q3 2023 reduction was Broadcom, cutting an estimated $343M.
- Los Angeles Capital Management fully exited Paycom in Q3 2023, selling an estimated $93.2M.
- Los Angeles Capital Management's ten largest holdings make up 34% of its $23.6B portfolio in Q3 2023.
- Los Angeles Capital Management opened 126 new positions and closed 172 in Q3 2023.
- Los Angeles Capital Management's portfolio value fell 5.5% quarter-over-quarter to $23.6B.
Based on Los Angeles Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.